Mumbai-based drug maker Alkem launched an antibiotic on Monday to treat multiple drug-resistant infections. The firm became the first from India to launch a novel antibiotic combination for treating drug-resistant infections, the company claimed.
The antibiotic, a combination of ceftazidime and avibactam, will be sold under the brand name Zidavi. It is indicated for various ailments such as complicated urinary tract infection. It is available at a price of Rs 2,700 per vial. Zidavi is manufactured in the company’s Sikkim facility.
With the rise in infections caused by carbapenem-resistant Gram-negative organisms in India, there is a need for more effective